Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
34.15
+0.02 (0.06%)
At close: May 22, 2026, 4:00 PM EDT
34.15
0.00 (-0.01%)
After-hours: May 22, 2026, 7:57 PM EDT
Immunovant Employees
Immunovant had 315 employees as of March 31, 2026. The number of employees decreased by 47 or -12.98% compared to the previous year.
Employees
315
Change (1Y)
-47
Growth (1Y)
-12.98%
Revenue / Employee
n/a
Profits / Employee
-$1,605,098
Market Cap
7.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 315 | -47 | -12.98% |
| Mar 31, 2025 | 362 | 155 | 74.88% |
| Mar 31, 2024 | 207 | 43 | 26.22% |
| Mar 31, 2023 | 164 | 40 | 32.26% |
| Mar 31, 2022 | 124 | 56 | 82.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Corcept Therapeutics | 730 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Rhythm Pharmaceuticals | 414 |
| Kymera Therapeutics | 253 |
| Nuvalent | 234 |
IMVT News
- 2 days ago - Immunovant price target raised to $30 from $23 at Truist - TheFly
- 3 days ago - Immunovant price target raised to $43 from $32 at BofA - TheFly
- 3 days ago - Immunovant price target raised to $40 from $35 at H.C. Wainwright - TheFly
- 4 days ago - Immunovant rises 33.6% - TheFly
- 4 days ago - This Is Why Immunovant Stock (IMVT) Is Up Today - TipRanks
- 4 days ago - 2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug - Barrons
- 4 days ago - Immunovant Q4 Earnings Call Highlights - MarketBeat
- 4 days ago - Immunovant rises 25.9% - TheFly